DrugPatentWatch Database Preview
US Patent Family Members and Approved Drugs for European Patent Office Patent: 1725253
Join the DrugPatentWatch Referral Program Get access to a free drug patent landscape report or a free one-month subscription
US Patent Family Members and Approved Drugs for European Patent Office Patent: EP1725253
US Patent Number | Estimated Patent Expiration | Generic Name | US Applicant | US Tradename |
---|---|---|---|---|
Start Trial | 2030-03-30 | onabotulinumtoxina | Allergan | BOTOX |
Start Trial | 2030-03-30 | onabotulinumtoxina | Allergan | BOTOX COSMETIC |
Start Trial | 2030-03-30 | onabotulinumtoxina | Allergan | BOTOX |
Start Trial | 2030-03-30 | onabotulinumtoxina | Allergan | BOTOX COSMETIC |
Start Trial | 2030-03-30 | onabotulinumtoxina | Allergan | BOTOX |
Start Trial | 2030-03-30 | onabotulinumtoxina | Allergan | BOTOX COSMETIC |
>US Patent Number | >Estimated Patent Expiration | >Generic Name | >US Applicant | >US Tradename |